BIO-FD&C Statistics

Total Valuation

BIO-FD&C has a market cap or net worth of KRW 114.70 billion. The enterprise value is 70.17 billion.

Market Cap	114.70B
Enterprise Value	70.17B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

BIO-FD&C has 8.70 million shares outstanding. The number of shares has decreased by -3.60% in one year.

Current Share Class	n/a
Shares Outstanding	8.70M
Shares Change (YoY)	-3.60%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	31.39%
Owned by Institutions (%)	0.22%
Float	5.15M

Valuation Ratios

The trailing PE ratio is 24.98 and the forward PE ratio is 14.23.

PE Ratio	24.98
Forward PE	14.23
PS Ratio	7.00
PB Ratio	1.78
P/TBV Ratio	1.83
P/FCF Ratio	24.00
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.57, with an EV/FCF ratio of 14.68.

EV / Earnings	15.59
EV / Sales	4.37
EV / EBITDA	11.57
EV / EBIT	14.46
EV / FCF	14.68

Financial Position

The company has a current ratio of 12.78, with a Debt / Equity ratio of 0.02.

Current Ratio	12.78
Quick Ratio	12.03
Debt / Equity	0.02
Debt / EBITDA	0.22
Debt / FCF	0.28
Interest Coverage	76.45

Financial Efficiency

Return on equity (ROE) is 7.39% and return on invested capital (ROIC) is 4.88%.

Return on Equity (ROE)	7.39%
Return on Assets (ROA)	4.66%
Return on Invested Capital (ROIC)	4.88%
Return on Capital Employed (ROCE)	7.66%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.25
Inventory Turnover	2.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.65% in the last 52 weeks. The beta is 0.58, so BIO-FD&C's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+8.65%
50-Day Moving Average	13,769.20
200-Day Moving Average	14,646.15
Relative Strength Index (RSI)	39.11
Average Volume (20 Days)	17,617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIO-FD&C had revenue of KRW 16.07 billion and earned 4.50 billion in profits. Earnings per share was 528.00.

Revenue	16.07B
Gross Profit	11.21B
Operating Income	4.85B
Pretax Income	5.23B
Net Income	4.50B
EBITDA	6.07B
EBIT	4.85B
Earnings Per Share (EPS)	528.00

Full Income Statement

Balance Sheet

The company has 45.89 billion in cash and 1.36 billion in debt, giving a net cash position of 44.53 billion or 5,121.00 per share.

Cash & Cash Equivalents	45.89B
Total Debt	1.36B
Net Cash	44.53B
Net Cash Per Share	5,121.00
Equity (Book Value)	63.13B
Book Value Per Share	7,417.59
Working Capital	46.87B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.04 billion and capital expenditures -1.26 billion, giving a free cash flow of 4.78 billion.

Operating Cash Flow	6.04B
Capital Expenditures	-1.26B
Free Cash Flow	4.78B
FCF Per Share	549.53

Full Cash Flow Statement

Margins

Gross margin is 69.80%, with operating and profit margins of 30.20% and 28.01%.

Gross Margin	69.80%
Operating Margin	30.20%
Pretax Margin	32.54%
Profit Margin	28.01%
EBITDA Margin	37.75%
EBIT Margin	30.20%
FCF Margin	29.74%

Dividends & Yields

BIO-FD&C does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.60%
Shareholder Yield	3.60%
Earnings Yield	3.92%
FCF Yield	4.17%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIO-FD&C has an Altman Z-Score of 19.76.

Altman Z-Score	19.76
Piotroski F-Score	n/a